A brain molecule has been found to reverse movement deficits in Parkinson’s, presenting a new potential therapeutic target. A ...

Parkinson's symptoms mainly result from the death or impairment of dopamine-producing neurons in the brain's substantia nigra ...

A sparkling shot... almost magical, to treat Parkinson's. American researchers have conducted several clinical trials, rather ...

Parkinson's disease is a chronic and progressive disorder that affects the central nervous system, primarily the brain, and ...

Shares in MeiraGTx rose after the company said it received positive data in a clinical bridging study of AAV-GAD for the treatment of Parkinson's disease. Shares were up nearly 14% in premarket ...

30, 2024 — Researchers have found a way to better control the preclinical generation of key neurons depleted in Parkinson's disease, pointing toward a new approach for a disease with no cure and few ...

Scientists found that damage to part of the gut could put you at a significantly higher risk of Parkinson's disease.

Norton Neuroscience Institute is the first and only facility in Kentucky to offer MRI-guided high-frequency focused ...

Exciting results for MeiraGTx Holdings plc's GAD gene therapy for Parkinson's Disease, with promising phase 1/2 data and ...

Norton Healthcare is now able to offer patients suffering from Essential Tremors and Parkinson's Disease some relief. The ...